Completed
Pilot Study of Ensifentrine or Placebo Delivered Via pMDI in Hospitalized Patients With COVID-19
NCT04527471
- Conditions
- COVID-19, Coronaviridae Infections, Coronavirus Infection, +11 more
- Locations
-
- The University of Alabama at Birmingham Birmingham, Alabama, United States